INCHEON, South Korea and SAN FRANCISCO, Aug. 23, 2019 /PRNewswire/ -- Voronoi, a drug discovery and development biotech company in Korea announced today that it has, after an extensive evaluation ...
Voronoi announced on April 30 that the company has demonstrated the potential of a safe targeted anticancer therapy through early clinical data for its EGFR non-small cell lung cancer targeted therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback